Date Insider Type Main position Quantity % Market Cap. Importance
8/28/20 Tax

General Counsel

997 0.0007%
8/28/20 Tax

Executive/Senior Manager

281 0.0002%
8/28/20 Tax

Chief Financial Officer

256 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.65%-10.00% - - 3.6M
+2.02%-0.96%+50.69%+92.40% 994B
+0.28%-3.24%+49.57%+62.65% 640B
+1.81%+2.07%+19.89%+70.38% 454B
+5.00%+2.21%+36.64%+39.24% 337B
+1.68%-9.20%+15.25%+24.87% 261B
+3.81%+0.93%+3.05%+12.39% 246B
+1.10%-12.75%+38.03%+45.44% 204B
+1.43%-6.21%-19.49%-58.94% 190B
+1.87%-3.04%+27.81%+89.26% 178B
Average +1.87%-4.63%+24.60%+41.97% 389.42B
Weighted average by Cap. +1.60%-3.19%+33.46%+57.27%
Logo Akorn, Inc.
Akorn Inc. (Akorn), together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals in a range of dosage forms, including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals and nasal sprays and otics. The Consumer Health segment consists of branded and private-label OTC products and animal health products dispensed by veterinary professionals. Its branded and private-label OTC products are focused on ophthalmics, including a dry eye treatment TheraTears Therapy for Your Eyes.
Employees
-
  1. Stock Market
  2. Stocks
  3. AKRXQ Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!